Related references
Note: Only part of the references are listed.Cerebrospinal Fluid A beta(42/40) Corresponds Better than A beta(42) to Amyloid PET in Alzheimer's Disease
Piotr Lewczuk et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation
Julia Kuhlmann et al.
CLINICA CHIMICA ACTA (2017)
Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid
Tobias Bittner et al.
ALZHEIMERS & DEMENTIA (2016)
Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements
Maria Bjerke et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease
Ann De Vos et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes
Hugo Marcel Johan Vanderstichele et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics
Natalia Lelental et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease
Ellis Niemantsverdriet et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42/Aβ1-40 ratio - a cross-validation study against amyloid PET
Josef Pannee et al.
JOURNAL OF NEUROCHEMISTRY (2016)
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Transferring Cut-off Values between Assays for Cerebrospinal Fluid Alzheimer's Disease Biomarkers
Leandro Garcia Barrado et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Validation of a commercially available enzyme-linked immunoabsorbent assay for the quantification of human α-Synuclein in cerebrospinal fluid
Niels Kruse et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study
Niels Kruse et al.
NEUROBIOLOGY OF AGING (2015)
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls
Hlin Kvartsberg et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
Maartje I. Kester et al.
JAMA NEUROLOGY (2015)
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
Courtney L. Sutphen et al.
JAMA NEUROLOGY (2015)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Cerebrospinal fluid biomarkers in Parkinson disease
Lucilla Parnetti et al.
NATURE REVIEWS NEUROLOGY (2013)
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
Hugo Vanderstichele et al.
ALZHEIMERS & DEMENTIA (2012)
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update
Marta del Campo et al.
BIOMARKERS IN MEDICINE (2012)
Brain Amyloid Imaging - FDA Approval of Florbetapir F18 Injection
Lucie Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Red blood cells are the major source of alpha-synuclein in blood
Robin Barbour et al.
NEURODEGENERATIVE DISEASES (2008)
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
S. W. Scheff et al.
NEUROLOGY (2007)
Share Paper
